[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.241.171. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1993

One-Year Results of Semiconductor Transscleral Cyclophotocoagulation in Patients With Glaucoma

Author Affiliations

From the Glaucoma Service, Department of Ophthalmology, Medical University of South Carolina, Charleston. The authors have no commercial or proprietary interest in any product or company mentioned in this report.

Arch Ophthalmol. 1993;111(4):488-491. doi:10.1001/archopht.1993.01090040080035
Abstract

• We evaluated 30 consecutive patients with glaucoma treated with semiconductor diode transscleral cyclophotocoagulation to determine the results and complications of this procedure. Twelve months after surgery the mean (±SD) preoperative intraocular pressure of 32.5±10.9 mm Hg (n=30) had dropped to 20.8±15.6 mm Hg (n=19) (P=.018, paired Student's t test), while the mean number of preoperative medications received decreased from 2.0 to 1.8 (P=.060, Wilcoxon's Signed Rank Test). One year after surgery three patients (10%) were unavailable for follow-up, eight (27%) had required other surgical procedures to control the intraocular pressure, 17 (56%) had controllable intraocular pressure of 21 mm Hg or below or received pain relief from the diode laser alone, and two (7%) patients with controlled intraocular pressure had suffered visual loss. Other complications included mild conjunctival hyperemia and uveitis in all patients and mild ocular pain in six patients. This study suggests the usefulness of diode transscleral cyclophotocoagulation in reducing the intraocular pressure for up to 1 year.

References
1.
Hennis HL, Stewart WC.  Semiconductor diode laser transscleral cyclophotocoagulation in patients with glaucoma . Am J Ophthalmol . 1992;113:81-85.
2.
Hennis HL, Assia E, Stewart WC, Legler UFC, Apple DJ.  Transscleral cyclophotocoagulation using a semiconductor diode laser in cadaver eyes . Ophthalmic Surg . 1991;21:274-278.
3.
Assia EI, Hennis HL, Stewart WC, Legler UFC, Carlson AN, Apple DJ.  Comparison of Nd: YAG and diode transscleral cyclophotocoagulation and cyclocryotherapy . Invest Ophthalmol Vis Sci . 1991;32:2774-2778.
4.
Schuman JS, Jacobson JJ, Puliafito CA, Noecker RJ, Reidy WT.  Experimental use of semiconductor diode laser in contact transscleral cyclophotocoagulation in rabbits . Arch Ophthalmol . 1990;108:1152-1157.Article
5.
Monsour M, Kane H, Gaasterland D.  Transscleral cyclophotocoagulation in human autopsy eyes: contact diode compared with noncontact Nd/YAG lasers . Invest Ophthalmol Vis Sci Suppl . 1992;33:1018.
6.
Kida K, Kuwayama Y, Takeuchi R, Uchihori Y.  Non-contact transscleral semi-conductor diode laser cyclophotocoagulation for refractory glaucoma . Invest Ophthalmol Vis Sci Suppl . 1992;33:1267.
7.
Carassa RG, Trabucchi G, Bettin P, Fiori M, Brancato R.  Contact transscleral cyclophotocoagulation (CTCP) with diode laser: a pilot clinical study . Invest Ophthalmol Vis Sci Suppl . 1992;33:1019.
8.
Gaasterland DE, Abrams DA, Belcher CD, et al.  A multicenter study of contact diode laser transscleral cyclophotocoagulation in glaucoma patients . Invest Ophthalmol Vis Sci Suppl . 1992;33:1019.
9.
Simmons RB, Shields MB, Blasini M, Wilkerson M, Stern RA.  Transscleral Nd:YAG laser cyclophotocoagulation with a contact lens . Am J Ophthalmol . 1991;112:671-677.
10.
Hampton C, Shields MB, Miller KN, Blasini M.  Evaluation of a protocol for transscleral neodymium:YAG cyclophotocoagulation in one hundred patients . Ophthalmology . 1990;97:910-917.Article
11.
Kalenak JW, Parkinson JM, Kass MA, Kolker AE.  Transscleral neodymium:YAG laser cyclocoagulation for uncontrolled glaucoma . Ophthalmic Surg . 1990;21:346-351.
12.
Cohen EJ, Schwartz LW, Lukind RD, et al.  Neodymium:YAG laser transscleral cyclophotocoagulation for glaucoma after penetrating keratoplasty . Ophthalmic Surg . 1989;20:713-716.
13.
Badeeb O, Trope GE, Mortimer C.  Short-term effects of neodymium-YAG transscleral cyclocoagulation in patients with uncontrolled glaucoma . Br J Ophthalmol . 1988;72:615-617.Article
14.
Balazsi G.  Noncontact thermal mode Nd: YAG laser transscleral cyclocoagulation in the treatment of glaucoma: intermediate follow-up . Ophthalmology . 1991;98:1858-1863.Article
15.
Noureddin BN, Wilson-Holt N, Lavin M, Jeffrey M, Hitchings RA.  Advanced uncontrolled glaucoma: Nd:YAG cyclophotocoagulation or tube surgery . Ophthalmology . 1992;99:430-437.Article
16.
Suzuki Y, Araie M, Yumita A, Yamamoto T.  Transscleral Nd:YAG laser cyclophotocoagulation versus cyclocryotherapy . Graefes Arch Clin Exp Ophthalmol . 1991;229:33-36.Article
17.
Wright MM, Grajewski AL, Feuer WJ.  Nd: YAG cyclophotocoagulation: outcome of treatment for uncontrolled glaucoma . Ophthalmic Surg . 1991;22:279-283.
×